CAMBRIDGE, Mass., Feb. 13, 2014 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases, announced that the Company will host a conference call and live audio webcast at 8:30 a.m. EST on Wednesday, February 26, 2014, to provide a business update, and to discuss its fourth-quarter and full-year 2013 financial and operational results.
Help employers find you! Check out all the jobs and post your resume.
